steady state for modified release [Regulatives / Guidelines]

posted by Kelen – Brazil, 2019-09-20 20:04 (488 d 17:01 ago) – Posting: # 20636
Views: 3,583

I would like to ask help for understand the objetive of the steady state study when you are comparing a MR formulation with a IR formulation. The objective would be compare the effect of the accumulation? Is there any reason to conduct the study only with de highest dose?

Edit: Please follow the Forum’s Policy[Helmut]

Complete thread:

 Admin contact
21,308 posts in 4,444 threads, 1,489 registered users;
online 3 (0 registered, 3 guests [including 2 identified bots]).
Forum time: Thursday 12:05 CET (Europe/Vienna)

Politicians use statistics like drunkards use lampposts:
not for illumination, but for support.    attributed to Hans Kuhn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz